drugset / Trial / NCT03223272
Mechanisms of Refractory Hypertension (Reserpine)
NaSingle-groupOpen-labelTreatment
Summary
The study is deigned to determine if refractory hypertension is attributable to heightened sympathetic tone by quantifying the antihypertensive benefit of reserpine, a sympatholytic agent, in patients failing other classes of antihypertensive agents.
Timeline
- Start
- 2015-07-23
- Primary completion
- 2020-01-31
- Completion
- 2020-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | reserpine | Small molecule | 0.1 mg | Oral |